Aggressive characteristics of myeloblasts expressing CD7 in myelodysplastic syndromes

Leukemia Research

Volumn 33, Issue 2, 2009, Pages 326-331

  Satoh, Chikako ^a   Tamura, Hideto ^a   Yamashita, Taishi ^a,b   Tsuji, Takashi ^b   Dan, Kazuo ^a   Ogata, Kiyoyuki ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Apoptosis; CCL2; CD34; CD7; IL 8; Myeloblasts; Myelodysplastic syndromes

Indexed keywords

CD34 ANTIGEN; CD7 ANTIGEN; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CYCLE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MYELOBLAST; MYELODYSPLASTIC SYNDROME; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MOTIF; REFRACTORY ANEMIA WITH EXCESS BLASTS;

ANTIGENS, CD7; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; CHEMOKINES, C; GRANULOCYTE PRECURSOR CELLS; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-8; MYELODYSPLASTIC SYNDROMES; TUMOR CELLS, CULTURED;

EID: 56949095018     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.07.006     Document Type: Article

References (29)

1. Stillwell R., and Bierer B.E. T cell signal transduction and the role of CD7 in costimulation. Immunol. Res. 24 (2001) 31-52
2. Carrera A.C., Rincon M., Sanchez-Madrid F., Lopez-Botet M., and de Landazuri M.O. Triggering of co-mitogenic signals in T cell proliferation by anti-LFA-1 (CD18, CD11a), LFA-3, and CD7 monoclonal antibodies. J. Immunol. 141 (1988) 1919-1924
3. Costantinides Y., Kingsley G., Pitzalis C., and Panayi G.S. Inhibition of lymphocyte proliferation by a monoclonal antibody (RFT2) against CD7. Clin. Exp. Immunol. 85 (1991) 164-167
4. Hou Z., Leta E., and Jung L.K. Cross-linking CD7 on myeloblasts results in granulocyte-macrophage colony-stimulating factor production. Blood 88 (1996) 124-129
5. Ogata K., Yokose N., Shioi Y., Ishida Y., Tomiyama J., Hamaguchi H., et al. Reappraisal of the clinical significance of CD7 expression in association with cytogenetics in de novo acute myeloid leukaemia. Br. J. Haematol. 115 (2001) 612-615
6. Venditti A., Del Poeta G., Buccisano F., Tamburini A., Cox-Froncillo M.C., Aronica G., et al. Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia. Leukemia 12 (1998) 1056-1063
7. Normann A.P., Egeland T., Madshus I.H., Heim S., and Tjonnfjord G.E. CD7 expression by CD34+ cells in CML patients, of prognostic significance?. Eur. J. Haematol. 71 (2003) 266-275
8. Yong A.S., Szydlo R.M., Goldman J.M., Apperley J.F., and Melo J.V. Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CML. Blood 107 (2006) 205-212
9. Ogata K., Nakamura K., Yokose N., Tamura H., Tachibana M., Taniguchi O., et al. Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. Blood 100 (2002) 3887-3896
10. Ogata K., and Yoshida Y. Clinical implications of blast immunophenotypes in myelodysplastic syndromes. Leuk Lymphoma 46 (2005) 1269-1274
11. van de Loosdrecht A.A., Westers T.M., Westra A.H., Drager A.M., van der Velden V.H., and Ossenkoppele G.J. Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry. Blood 111 (2008) 1067-1077
12. Chiba S., Takaku F., Tange T., Shibuya K., Misawa C., Sasaki K., et al. Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36: a parental line requiring granulocyte-macrophage colony-stimulating factor or interleukin-3, and a subline requiring erythropoietin. Blood 78 (1991) 2261-2268
13. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., et al. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 51 (1982) 189-199
14. Greenberg P., Cox C., LeBeau M.M., Fenaux P., Morel P., Sanz G., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89 (1997) 2079-2088
15. Ogata K., Satoh C., Tachibana M., Hyodo H., Tamura H., Dan K., et al. Identification and hematopoietic potential of CD45- clonal cells with very immature phenotype (CD45-CD34-CD38-Lin-) in patients with myelodysplastic syndromes. Stem Cells 23 (2005) 619-630
16. Tsuji T., Itoh K., Nishimura-Morita Y., Watanabe Y., Hirano D., Mori K.J., et al. CD34high+ CD38(low/-) cells generated in a xenogenic coculture system are capable of both long-term hematopoiesis and multiple differentiation. Leukemia 13 (1999) 1409-1419
17. Ogata K., Kishikawa Y., Satoh C., Tamura H., Dan K., and Hayashi A. Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes. Blood 108 (2006) 1037-1044
18. Piva R., Gianferretti P., Ciucci A., Taulli R., Belardo G., and Santoro M.G. 15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins. Blood 105 (2005) 1750-1758
19. Shioi Y., Tamura H., Yokose N., Satoh C., Dan K., and Ogata K. Increased apoptosis of circulating T cells in myelodysplastic syndromes. Leuk. Res. 31 (2007) 1641-1648
20. Satoh J., Nakanishi M., Koike F., Onoue H., Aranami T., Yamamoto T., et al. T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients. J. Neuroimmunol. 174 (2006) 108-118
21. Nakao K., Itoh M., Tomita Y., Tomooka Y., and Tsuji T. FGF-2 potently induces both proliferation and DSP expression in collagen type I gel cultures of adult incisor immature pulp cells. Biochem. Biophys. Res. Commun. 325 (2004) 1052-1059
22. Behringer D., Schaufler J., Kresin V., Lubbert M., and Lindemann A. Differentiation associated modulation of the cytokine and chemokine expression pattern in human myeloid cell lines. Leuk. Res. 25 (2001) 141-149
23. Cignetti A., Vallario A., Roato I., Circosta P., Strola G., Scielzo C., et al. The characterization of chemokine production and chemokine receptor expression reveals possible functional cross-talks in AML blasts with monocytic differentiation. Exp. Hematol. 31 (2003) 495-503
24. Zhou L., Azfer A., Niu J., Graham S., Choudhury M., Adamski F.M., et al. Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction. Circ. Res. 98 (2006) 1177-1185
25. Lo Coco F., De Rossi G., Pasqualetti D., Lopez M., Diverio D., Latagliata R., et al. CD7 positive acute myeloid leukaemia: a subtype associated with cell immaturity. Br. J. Haematol. 73 (1989) 480-485
26. Kurtzberg J., Waldmann T.A., Davey M.P., Bigner S.H., Moore J.O., Hershfield M.S., et al. CD7+, CD4-, CD8- acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells. Blood 73 (1989) 381-390
27. Nilsson L., Astrand-Grundstrom I., Arvidsson I., Jacobsson B., Hellstrom-Lindberg E., Hast R., et al. Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level. Blood 96 (2000) 2012-2021
28. Guzman M.L., Rossi R.M., Neelakantan S., Li X., Corbett C.A., Hassane D.C., et al. An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. Blood 110 (2007) 4427-4435
29. Hassane D.C., Guzman M.L., Corbett C., Li X., Abboud R., Young F., et al. Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data. Blood 111 (2008) 5654-5662